Dam Kim

Dam Kim

Auto-generated profile, based on publicly available information

Dam Kim

Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2018 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
SWSoyoung Won
Soyoung Won
SCSoo-Kyung Cho
Soo-Kyung Cho
DKDam Kim
Dam Kim
MHMINKYUNG HAN
MINKYUNG HAN
JLJiyoung Lee
Jiyoung Lee
SBSuk-Chul Bae
Suk-Chul Bae

9 August 2016 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
SCSoo-Kyung Cho
Soo-Kyung Cho
YSYoon-Kyoung Sung
Yoon-Kyoung Sung
DKDam Kim
Dam Kim
SWSoyoung Won
Soyoung Won
CCChan-Bum Choi
Chan-Bum Choi
SBSuk-Chul Bae
Suk-Chul Bae
The concerns about the development of adverse events (AEs) in elderly RA patients as a result of age-related changes in drug metabolism and the presence of comorbid illnesses are emphasizing due to increasing prevalence of rheumatoid arthritis (RA) in old age. However, they tend to be inadequately represented in RA clinical trials because of the exclusion criteria that are commonly applied. The tolerability and safety of TNF inhibitors in elderly patients have not been also evaluated in clinical practice. This study aimed to evaluate the retention rate and safety of TNF inhibitors (TNFI) in elderly RA patients. Total 429 RA patients (838 person-years [PYs]) treated with TNFI from a retrospective biologic DMARDs registry. Patients were divided into an elderly (age ≥60 years) and a younger group (<60 years). The drug retention rates of both groups were compared using Kaplan-Meier curves. Potential predictors of TNFI discontinuation in the elderly were examined using Cox regression analysis. The incidence rate (IR) of serious adverse events (SAEs) in the elderly group was compared to that of the young group. Of the patients, 24.9 % (n = 107, 212 PYs) were in the elderly group. Regarding the retention rates of TNFI in 3 years, there was no significant difference between the elderly and younger group (p = 0.33). The major cause of discontinuation in elderly patients was AE (34.3 %), whereas that was drug ineffectiveness (41.7 %) in younger patients. Age (HR 1.09, CI 1.02-1.16) was a predictor of discontinuation, while the presence of comorbidity (HR 0.37, CI 0.15-0.91) had a protective effect against drug discontinuation in the elderly. The IR of SAEs in the elderly (6.13/100 PYs) was higher than in the younger group (5.11/100 PYs). The retention rate of TNFI in the elderly was comparable with that in younger patients. The major cause of discontinuation in the elderly patients was AEs, while it was drug ineffectiveness in younger patients. The IR of SAEs in the elderly was higher than in the younger patients.


8 January 2015 in Genes & Immunity
Verified
Journal Article
Closed access
PDF file
MMM Martins
M Martins
AWA H Williams
A H Williams
MCM Comeau
M Comeau
MMM Marion
M Marion
JZJ T Ziegler
J T Ziegler
CFC Fesel
C Fesel

1 January 2021 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
BKBon San Koo
Bon San Koo
DKDam Kim
Dam Kim
JJJae-Bum Jun
Jae-Bum Jun
Koo BS, et al. J Korean Med Sci. 2021 Oct;36(45):e303. https://doi.org/10.3346/jkms.2021.36.e303

1 January 2016 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
YSYoon-Kyoung Sung
Yoon-Kyoung Sung
SCSoo-Kyung Cho
Soo-Kyung Cho
DKDam Kim
Dam Kim
BYBo Young Yoon
Bo Young Yoon
CCChan-Bum Choi
Chan-Bum Choi
TIthe KORONA Investigators
the KORONA Investigators
Sung YK, et al. J Korean Med Sci. 2016 Dec;31(12):1907-1913. https://doi.org/10.3346/jkms.2016.31.12.1907